| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 20.65B | 8.14B | 11.97B | -27.59B | 26.50B |
| Gross Profit | 20.65B | 8.14B | 11.97B | -27.59B | 26.50B |
| EBITDA | 3.81B | 2.93B | 3.06B | -233.86M | 3.00B |
| Net Income | 2.96B | 2.29B | 1.70B | -1.01B | -2.04B |
Balance Sheet | |||||
| Total Assets | 157.48B | 181.88B | 174.07B | 160.25B | 188.23B |
| Cash, Cash Equivalents and Short-Term Investments | 5.72B | 2.44B | 1.59B | 1.81B | 7.17B |
| Total Debt | 4.48B | 4.72B | 4.87B | 5.08B | 8.24B |
| Total Liabilities | 141.63B | 163.20B | 156.08B | 143.35B | 169.12B |
| Stockholders Equity | 14.93B | 17.49B | 17.82B | 16.73B | 18.94B |
Cash Flow | |||||
| Free Cash Flow | 1.61B | 3.51B | 788.00M | 839.48M | 242.00M |
| Operating Cash Flow | 1.69B | 3.61B | 832.00M | 873.46M | 278.00M |
| Investing Cash Flow | 809.36M | -832.00M | -360.00M | -39.00M | -726.00M |
| Financing Cash Flow | -1.17B | -1.70B | -1.21B | -2.52B | 1.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $11.98B | 10.08 | 20.92% | 0.74% | 3.96% | 18.84% | |
79 Outperform | $58.15B | 13.81 | 13.05% | 2.10% | 7.06% | 37.42% | |
74 Outperform | $12.92B | 12.91 | 7.01% | 2.22% | 4.19% | -45.74% | |
69 Neutral | $37.48B | 3.72 | 40.09% | 1.49% | 66.84% | 83.13% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | $34.30B | 11.10 | 11.44% | 4.73% | -13.68% | 33.89% | |
58 Neutral | $52.31B | 15.53 | 12.01% | 2.78% | 8.59% | -21.11% |